Subtyping breast cancer PDX: androgen and glucocorticoid receptors, EGFR and lineage markers

LEFT-RIGHT EPIGENETIC AND BIOELECTRIC DIFFERENCES IN BREAST CANCER

GEF-H1 drives breast cancer cells to tumor formation and metastasis

Imidacloprid as a risk factor for breast cancer development

WNT5A IS INVOLVED IN THE PRO-TUMORIGENIC ROLE OF GPAT2 EXPRESSION IN MDA CELLS

Biological activity of two new copper(II)-neocuproine complexes and L-dipeptides (L-Ala-L-Phe) in two breast cancer cell lines.

IN VITRO EFFECT OF NEW HSP90 INHIBITORS ON BREAST CANCER CELLS

Effect of neonicotinoid insecticide imidacloprid exposure on breast cancer cells

HEMEOXIGENASE-1 GENETIC VARIANTS EFFECTS ON BREAST CANCER PROGRESSION

In vitro and in vivo effect of the combination of 2’-nitroflavone and safingol in breast cancer